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Introduction 
Chronic kidney disease (CKD) remains a prevalent issue in America. The National 
Kidney Foundation (2019) estimates that up to 37 million Americans are currently living with 
CKD. Of those 37 million, approximately 468,000 individuals are on dialysis (The National 
Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, 2016). This 
costs the Medicare system an average of $90,000 per patient annually in the United States, 
totaling $28 billion (University of California San Francisco, 2019). Dialysis patients have a far 
greater mortality rate than the general population, due to the complexity of the disease and other 
comorbidities impeding the maintenance of good health (UCSF, 2019). Preventing 
hospitalizations and complication due to CKD is essential to reduce healthcare costs and 
optimize patient well-being. 
One problem that affects CKD patients, particularly those on dialysis, is a condition 
known as mineral bone disease (MBD). Decrease in kidney function causes elevated levels of 
serum phosphate, hypercalcemia, and abnormal parathyroid hormone (PTH) leading to MBD 
(Kettele et al., 2018). These abnormal levels lead to numerous complications for patients that 
include increased cardiovascular disease, increased bone fragility, and an overall increase in 
patient mortality (Annuals of Internal Medicine, 2018). Data from 2016 showed that 
approximately 60% of U.S. dialysis patients had hyperphosphatemia, one of the main factors 
contributing to MBD (Djukanovic, et al 2016). A major issue in the CKD and dialysis population 
is ensuring patients control their diet to keep these levels within normal limits as recommended 
by Kidney Disease Improving Global Outcomes (KDIGO) guidelines and the National Kidney 
Foundation (Burton, Goldsmith, Ruddock, Shroff, & Wan, 2018). It is recommended that serial 
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assessment of phosphorus, calcium, and PTH levels should be evaluated together to more 
thoroughly assess for risk of MBD (Kidney International Supplements, 2017). Making dietary 
changes as needed to bring phosphate and calcium levels close to normal limits will help 
decrease maleffects associated with patients with end stage renal disease (ESRD).  
The goal of this project is to decrease the risk of MBD by educating CKD patients on 
basic understanding of this complication and ways to make better nutritional choices to improve 
their quality of life.  Anderson and Nguyen (2018) have shown education can help them 
overcome many additional obstacles they may face in the course of their illness by making better 
dietary choices. Effectiveness will be evaluated by assessing patient understanding and 
compliance using voluntary post surveys, while also looking for improvements in patient 
reported dietary choices.         
Aim  
This literature review had multiple goals. The first and primary goal was to establish the 
risks of MBD and the need to address the problem. The second aim was to establish what 
interventions have been successful in the prevention and treatment for managing MBD in 
dialysis patients with ESRD.  The third and final objective was to examine the literature and 
determine what hurdles currently undermine the effects of current treatment standards and how 
to best overcome those barriers.  
Search Strategy  
 Several databases were searched in an effort to find relevant literature. Databases that 
were searched include CINAHL Plus, Cochrane Database of Systematic Reviews, Google 
Scholar, MEDLINE complete, and PubMed. Keywords searched included the terms “mineral 
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bone disease,” “MBD,” “end stage renal disease,” “ESRD,” “dialysis complications,” “burden of 
mineral bone disease,” “kidney failure,” “non-compliance,” and “chronic kidney disease.” 
“nutrition and ESRD”.  Articles were limited to those published in English in an academic 
journal from the years of 2015 to present.  
Results 
Results of the original search for pertinent information yielded over 100 articles. Results 
were then narrowed down to only include those that presented level I and II research to review. 
Google Scholar, CINHAL, and PubMed produced the greatest amount of relevant literature. No 
difficulties were encountered in finding relevant research on non-compliance that were published 
between 2015- present. A total of 28 articles were reviewed and 17 were ultimately chosen to be 
used in the literature review. Several themes emerged including risk associated with mineral 
bone disease, goals of prevention and treatment, barriers of prevention and treatment. 
Risks Associated with Mineral Bone Disease.  
Djukanović et al (2016) studied over 1700 patients for a three-year period and found that 
phosphorus levels outside of 2.5-4.5 mg/dl and intact PTH levels outside of 10-65pg/ml were 
associated with higher morbidity and mortality for patients. Abnormalities in these lab values put 
patients at increased risk for fractures, calcification of arteries, valves, and myocardium, and 
calciphylaxis. 38.7% of patients who die with ESRD die of an arrythmia or cardiac arrest 
(NIDDK, 2016). Another study in 2017 found that in patients over 70 years old more than 50% 
of fall injuries could be attributed to MBD and it was a causative factor in over two-thirds of fall 
related deaths (Sanchez-Riera, et al.  2017). 
Interventions to Aid in the Prevention and Treatment of Mineral Bone Disease.  
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The basis of both prevention and treatment of MBD is to follow a prescribed dietary 
regimen and use medication or supplementation as necessary to keep calcium, phosphorus, and 
PTH levels as close to normal levels as possible. Effective dialysis can only remove between 
250mg-1000mg per treatment (Davita, 2018).  Patients frequently have high levels of 
phosphorus, as kidneys are responsible for most of excretion (Copland, Komenda, Weinhandl, 
McCullough, & Morfin, 2016). Adherence to dietary recommendations is difficult as many 
patients are low income so have greater difficulty accessing healthier food. Further, labeling that 
shows actual phosphorus levels in food and drinks is limited (Copland, Komenda, Weinhandl, 
McCullough, & Morfin, 2016). To help combat dietary intake of phosphorus, phosphate binders 
are recommended (Kidney International Supplements, 2017).  
Calcium levels are indirectly controlled by kidney function and therefore frequent 
monitoring of these levels needs to be done to keep them within normal limits. Dietary adherence 
is important, but sometimes supplementation is necessary. Conservative supplementation is 
suggested as risks of hypercalcemia are greater for ESRD patients than those of hypocalcemia 
(Burton, Goldsmith, Ruddock, Shroff, & Wan, 2018).  Bone mineral density studies are 
recommended by KDIGO to identify those at risk of fractures due to abnormal calcium levels. 
Lastly, secondary hyperparathyroidism can occur from loss of kidney function. This can be 
controlled by controlling phosphorus and Vit D intake, by removal of parathyroid gland or 
medication administration (Chen, et al, 2018).  
Due to the demands of dietary guidelines and restrictions it can often be difficult for 
patients and their caregivers to manage food choices. Studies have shown the importance of a 
multi-disciplinary approach to managing MBD in patients with CKD (Chan, Cheah, & Padzil, 
2019; Anderson and Nguyen, 2018; Milazi, Bonner, & Douglas, 2015). A key component all of 
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these studies denotes the value of dietary education for patients and their caregivers. The study 
by Chan, Cheah, and Padzil (2019) showed that the combination of dietary and medication 
education dropped phosphate levels from 1.86 mmol/L to 1.47 mmol/L in just 3 months after 
administration of education. In a separate systematic review, the importance of a 
multidisciplinary approach including dietary restriction, oral medication, therapy and 
hemodialysis was indicated. The review found dietary education can improve both compliance 
and electrolyte levels (Milazi, Bonner, Douglas, 2015). Additionally, Anderson and Nguyen 
(2018) clearly state that nutritional education is recommended for patients with ESRD and 
cardiovascular disease (CVD).  
Barriers to Prevention and Treatment of Mineral Bone Disease.  
Adherence to dietary constraints as well as medication regimen can be difficult. Patients 
may be prescribed phosphate binders to be taken at each meal and snack. This pill burden can 
cause noncompliance if a patient forgets to carry their medication along with them wherever they 
go (Copland, Komenda, Weinhandl, McCullough, & Morfin, 2016). One study suggests that 
patients skip up to 57% of their phosphate binder medication doses and found that the greater the 
number of pills the patient is required to take the greater likelihood of non-compliance (Fissell, et 
al. 2016). Also, as stated previously, many patients who suffer from ESRD are of low economic 
status, their ability to afford more nutrient dense foods is more limited, and proper labeling of 
phosphorus content in food/drinks are limited. To combat these problems, short daily 
hemodialysis and nocturnal hemodialysis are recommended to help decrease pill burden and 
decrease mortality (Fissell, et al, 2016). However, compliance with even the standard 3 times 
weekly in center hemodialysis is low (Copland, Komenda, Weinhandl, McCullough, & Morfin, 
2016). 
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Discussion 
High blood pressure and diabetes are the major contributing factors to developing CKD 
accounting for 75% of kidney failure cases between 2014-2016 (NKF, 2019). African American, 
Native Americans, Mexican Americans, and Asian Americans all have higher rates of CKD than 
Caucasians (NIDDK, 2016). Early education is important for prevention in developing CKD and 
ESRD. Twelve people die every day waiting for a transplant (NKF, 2019). Therefore, the goal to 
prevent further complications with patients with CKD and ESRD is paramount. MBD is a 
common complication for these patients due to kidney not being able to process phosphorus, 
calcium, and regulate PTH effectively. Providing simplistic education that suggests feasible 
changes to diet can have a long-lasting impact not just on the prevention and treatment of 
mineral bone disease but on other common comorbidities such as diabetes mellitus and 
congestive heart failure.  
Conclusion 
The reviewed literature pointed toward the clear dangers MBD poses to a dialysis 
patient’s mortality and their quality of life. These dangers do not only affect the patient, but also 
their family and caregivers, creating an increased burden on the health care system. There is a 
clear need to prevent MBD and its associated complications. However, due to several barriers 
including non-compliance and low economic status, interventions must be simple and cost-
effective. For example, small, easy, and affordable changes, such as healthier food choices, that 
require little effort on the patient’s part are achievable and could eventually decrease the 
patient’s pill burden and lead to greater compliance. Numerous studies have shown a clear 
correlation between nutritional education and decreased complications in CKD and MBD (Chan, 
Cheah, & Padzil, 2019; Anderson and Nguyen, 2018; Milazi, Bonner, & Douglas, 2015). 
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Education would ideally be given at the same time as the patient’s dialysis treatment so there are 
no additional appointments that could further the burden on the patient and increase the risk of 
non-compliance. Easily referenced, simply presented guides should also be provided so the 
patient and their family can reference them when needed and do not need to memorize 
information. By providing continuing education at the time of dialysis, and increased 
accessibility to reference guides that suggest uncomplicated, cost-effective changes, those with 
the disease can take better control of their health and lower their risk of complications and 
prevent their chances of developing mineral bone disease.  
